Drug Security: International Cooperation and the Search for Joint Solutions
Current global challenges and the geopolitical situation dictate the need to build reliable partnerships with friendly countries, including to ensure drug security issues. It is necessary to create international platforms for dialogue between regulators, business, and professional communities to discuss harmonization of requirements for registration of medicines and certification of their production processes. Sharing experiences, removing excessive administrative barriers, and harmonizing requirements will facilitate the development and market launch of safe, effective, and high-quality medicines in the most resource-efficient way. What obstacles and challenges do pharmaceutical producers face when entering international markets? What are the specifics of drug registration and manufacturing certification requirements in the Russian Federation and a number of partner countries? What steps are needed to harmonize the approaches of our countries and improve access to medicines? Which medicines manufactured in Russia have a competitive export potential for international pharmaceutical markets?
Moderator
Mikhail Khomich,
Managing Director for International Development, VEB.RF; Special Projects Director, Agency for Strategic Initiatives to Promote New Projects (ASI)
Panellists
Hesa Sabah Al Doseri,
Chief, Health Facilities Regulation, National Health Regulatory Authority of the Kingdom of Bahrain (NHRA)
Sergey Glagolev,
Deputy Minister of Health of the Russian Federation
Olga Zhuravleva,
Deputy Director, Center for Examinations and Tests in Health Service
Valentina Kosenko,
General Director, Scientific Center for Expertise of Medicinal Products of the Ministry of the Ministry of Health of the Russian Federation
Igor Obrubov,
General Director, Rusatom Healthcare
Martha Veronica Reyes Alvarez,
Minister of Health of the Republic of Nicaragua
Siddhartha Sankar Datta,
Regional Adviser of Vaccine-preventable Diseases and Immunization Programme, World Health Organization Regional Office for Europe
Vladislav Shestakov,
Director, State Institute of Drugs and Good Practices
Tadzio Schilling,
Chief Executive Officer, Association of European Businesses (АЕВ)
Front row participants
Olesya Ledukhovskaya,
Founder, Asia Trade Group
Vadim Tarasov,
Director, Institute of Translational Medicine and Biotechnology Institute of Translational Medicine and Biotechnology, First Moscow State Medical University named after I.M. Sechenov
Victor Trukhin,
Director, Saint Petersburg Scientific Research Institute of Vaccines and Serums of the FMBA of Russia